Sermonix Pharmaceuticals Inc is a privately held, Ohio-based biopharmaceutical company with a precision medicine focus for bringing targeted oncology products through development, approval, and commercialization. Sermonix’s lead candidate is oral lasofoxifene. Lasofoxifene is currently under investigation in a phase 2 trial and is thought to be a potent third-generation selective estrogen receptor modulator (SERM) (also know...
Sermonix Pharmaceuticals Inc is a privately held, Ohio-based biopharmaceutical company with a precision medicine focus for bringing targeted oncology products through development, approval, and commercialization. Sermonix’s lead candidate is oral lasofoxifene. Lasofoxifene is currently under investigation in a phase 2 trial and is thought to be a potent third-generation selective estrogen receptor modulator (SERM) (also known as an estrogen agonist/antagonist) with high affinity for the estrogen receptor 1 (ESR1) receptor. Previous clinical development programs have suggested potential benefits to breast, bone, and vaginal tissue.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.